GE HealthCare (NASDAQ:GEHC) was cut to sell by UBS on Thursday, with the bank asserting that rewards were already priced into the stock, but not risks. UBS noted that GE HealthCare shares (GEHC) were up around 20% year-to-date and nearing all-time highs.

UBS has downgraded GE Healthcare Technologies Inc (NASDAQ:GEHC). to a 'sell' rating from a 'neutral' signaling growing concerns about the company's valuation and its exposure to competitive risks in the Chinese

Siemens Healthineers AG (ETR:SHLG) has been downgraded by UBS to a "neutral" rating from a "buy”, reflecting concerns over the company’s medium-term growth prospects. The downgrade stems from mounting challenges in

GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese competition were not priced into the stock. Read more here.